Posted on 01/28/2025 10:57:25 AM PST by ransomnote
SNIP
The disease afflicts nearly seven million Americans, about one in every nine people over the age of 65, making it a leading cause of death among older adults.
SNIP
Over the past 25 years, Alzheimer’s research has suffered a litany of ostensible fraud and other misconduct by world-famous researchers and obscure scientists alike, all trying to ascend in a brutally competitive field. During years of investigative reporting, I’ve uncovered many such cases, including several detailed for the first time in my forthcoming book.
Take for example the revered neuroscientist Eliezer Masliah, whose groundbreaking research has shaped the development of treatments for memory loss and Parkinson’s disease, and who in 2016 was entrusted to lead the National Institute on Aging’s expanded effort to tackle Alzheimer’s. With roughly 800 papers to his name, many of them considered highly influential, Dr. Masliah seemed a natural choice to steer the project, with billions in new funding. He hailed the moment as the dawning of “the golden era of Alzheimer’s disease research.”
Last September in Science magazine, I described evidence that for decades Dr. Masliah’s research had included improperly manipulated photos of brain tissue and other technical images — a clear sign of fraud. Many of his studies contained apparently falsified western blots — scientific images that show the presence of proteins in a blood or tissue sample. Some of the same images seem to have been used repeatedly, falsely represented as original, in different papers throughout the years. (When I reached out to Dr. Masliah for the story, he declined to respond.)
(Excerpt) Read more at nytimes.com ...
.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.